Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal proliferation of cytotoxic lymphocytes. Among them, ...
Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...
Large Granular Lymphocyte Leukemia (LGLL) is a rare, chronic lymphoproliferative disorder primarily defined by the clonal expansion of cytotoxic T cells or natural killer (NK) cells. Clinically, the ...
Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...
Abcuro to Present Interim Phase 1 Data Evaluating Ulviprubart in Patients with T Cell Large Granular Lymphocytic Leukemia at the 67th American Society of Hematology Annual Meeting Abcuro, Inc., a late ...
B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments in ...
Cancers driven by hiccups in RNA processing can’t hide from our immune system, according to new work published today in Cell. A cross-institutional team Fred Hutch Cancer Center and Memorial Sloan ...
Just like the cancer in any part of the body, which is characterized by uncontrolled growth of the cells, Leukemia is also a type of cancer that is developed and takes malignant form in our blood ...
Leukemic ocular involvement arises from direct infiltration, hematologic derangements (anemia, thrombocytopenia, hyperviscosity), opportunistic infections, or drug toxicity, and may be the first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results